Yüklüyor......
Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer
For locally advanced and metastatic head and neck squamous cell carcinoma (HNSCC), the current clinical use of Cetuximab in chemo/radiotherapy protocols is often associated to severe systemic toxicity. Here we report in vitro data in human FaDu pharynx SCC cells, showing that inactive concentrations...
Kaydedildi:
Yayımlandı: | Oncotarget |
---|---|
Asıl Yazarlar: | , , , , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Impact Journals LLC
2015
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808042/ https://ncbi.nlm.nih.gov/pubmed/26575422 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|